Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Decitabine Maintenance for Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) Post Transplant
ClinicalTrials.gov study NCT00986804. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effects of Music Therapy in Controlling Symptoms in Patients With AML and Undergoing HSCT
ClinicalTrials.gov study NCT05696457. IPD Sharing: NO. Countries: 1. Publications: 1.
Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01488344. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial
ClinicalTrials.gov study NCT07101588. IPD Sharing: NO. Countries: 1. Publications: 10.
Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60
ClinicalTrials.gov study NCT04687761. IPD Sharing: Not stated. Countries: 1. Publications: 18.
Study to Evaluate the Effect of Aprepitant in Children and Adolescents Receiving AML Remission Induction Chemotherapy
ClinicalTrials.gov study NCT02979548. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02834390. IPD Sharing: YES. Countries: 1. Publications: 0.
High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AML
ClinicalTrials.gov study NCT00474006. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pharmacokinetics Variability of Posaconazole (PCZ) and Its Glucuronide Metabolite During Induction and Consolidation Treatments in Patients With Acute Myeloid Leukemia (AML): a Covariate Analysis With
ClinicalTrials.gov study NCT03796533. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMML
ClinicalTrials.gov study NCT04730258. IPD Sharing: NO. Countries: 3. Publications: 1.
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS
ClinicalTrials.gov study NCT02576301. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Study of Chemotherapy in Combination With All-trans Retinoic Acid (ATRA) With or Without Gemtuzumab Ozogamicin in Patients With Acute Myeloid Leukemia (AML) and Mutant Nucleophosmin-1 (NPM1) Gene Muta
ClinicalTrials.gov study NCT00893399. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML
ClinicalTrials.gov study NCT02076191. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Gemtuzumab Ozogamicin in Induction and Glasdegib in Postremission Therapy in Patients With AML (Acute Myeloid Leukemia)
ClinicalTrials.gov study NCT04093505. IPD Sharing: NO. Countries: 1. Publications: 1.
Early Allogeneic Blood Stem Cell Transplantation in High-risk Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00188136. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Brentuximab Vedotin + Re-induction Chemotherapy for AML
ClinicalTrials.gov study NCT01830777. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Milademetan in Japanese Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT03671564. IPD Sharing: YES. Countries: 1. Publications: 0.
Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients
ClinicalTrials.gov study NCT02575963. IPD Sharing: NO. Countries: 2. Publications: 4.
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
ClinicalTrials.gov study NCT06138990. IPD Sharing: YES. Countries: 1. Publications: 3.
Trial for Relapsed or Refractory AML Patients Combining Cytarabine and Mitoxantrone With Venetoclax (RELAX)
ClinicalTrials.gov study NCT04330820. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.